Blood Screening Market: Industry Growth, Size, Share and Forecast 2018-2023
Posted by Orion Market Research on September 30th, 2019
The growing adoption of screening technologies such as nucleic acid amplification test, Western Blotting, Enzyme-Linked Immunosorbent Assay, and PCR-RNA is boosting the growth of the blood screening market during the forecast period. Rising implementation of NAT (Nucleic Acid Testing) with a positive impact to adopt cutting edge technologies in transfusion services across the globe is flourishing the growth of the market. In the early stage, NAT PCR (polymerase chain reaction) testing aids infection in donated blood that enhanced the value of blood safety. Moreover, voluntary donors have been found that have a lower incidence of TTI (Transfusion Transmitted Infections) as compared to replacement donors.
Browse the full report description of "Blood Screening Market, by Screening Technology (Nucleic Acid Amplification Test, Western Blotting, Enzyme-Linked Immunosorbent Assay, PCR-RNA), by Products (Testing Instruments, Reagents), by End-Users (Blood Banks, Hospitals, Laboratories) – Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2018-2023" at https://www.omrglobal.com/industry-reports/blood-screening-market
In September 2019, the prevalence of Hepatitis B is 4%, Hepatitis C is 1% and HIV is 0.26% in India and around 70% of HIV infected individual is aware regarding early detection. The introduction of NAT is considerable reduce many such infections and TTIs associated mortality. NAT directly detects the RNA & DNA of the virus named as HIV and Hepatitis C and B. It is the most sensitive technique for detection of the infectious blood screening test. It is an essential requirement for voluntary blood donor and growing adoption of better screening standards that include NAT PCR on the World Blood Donor Day.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/blood-screening-market
The test of Enzyme-Linked Immunosorbent Assay test (ELISA) is commonly utilized for the laboratory to detect antibodies in the blood for the screening test. ELISA used to screen for HIV infection due to its relatively simple methodology, suitability for testing a significant number of blood samples in blood testing centers and inherent large sensitivity. Approximately more than 40 different ELISA test kits are available and about 10 are licensed by the FDA (Food and Drug Administration) for utilization in the US. The ELISA test and Western blotting test is the blood antibody test which is used to detect HIV. Thus, due to the adoption of these techniques is boosting the growth of the blood screening market during the forecast period.
Blood screening for HIV, HCV, and HBV through serological tests for HBsAg to HIV and HCV is mandatory in India. The seronon blood donation is at risk of transferring of TTIs and due to this need for sensitive screening test occur to reduce the residual risk that has been decreased considerably in the country where NAT has been implemented. The awareness among people regarding NAT PCR is rising in India. Furthermore, in September 2019, around 9% donated blood get screened through NAT and currently NAT is not mandatory in India for the screening of TTIs.
Global Blood Screening Market Segmentation
By Screening Technology
Global Blood Screening Market – Segment by Region
Rest of the World
About Orion Market Research
OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404
Like it? Share it!
About the AuthorOrion Market Research
Joined: June 25th, 2018
Articles Posted: 331
More by this author